Thursday, February 19, 2009

How to Burn Xbox 360 games using Mac

Do you want to burn xbox 360 games using mac just encase your having a party and you dont want everyone messing up your original copies or you just want to be safe? It is rather easy to burn Xbox 360 games on your Mac.

Instructions

Step1
To starting burning your xbox 360 games using your mac open up x360 ISO Hacker. Insert your original Xbox 360 game you want to copy. Click the Copy tab and you need to change a few settings. Unclick Hacked Ripped ISO and Burn ISO, Select the location you want to save your ISO. Click Start

Step2
Once it is finished it is time to burn the xbox 360 game using your mac. Close x360 ISO Hacker. I know that the x360 ISO Hacker has a burn tab but I don't recommend it, thats why I suggest using iBurn.

Step3
Insert a blank DVD into your drive. Open Iburn click the refresh button so that the program will find that you have a blank DVD in your drive. Click the drop down menu and select the drive that the blank DVD is in.

Step4
No to start burning your XBox 360 game using mac. Open a finder window and locate where your saved ISO is. Drag the ISO into the white box that says drop your xbox 360 image here. Select your writing recording speed. I personally don't recommend using for 2.4x recording speed when burning your xbox 360 games. The faster you use the easier it is for there to be a write error.

Tips & Warnings

  • Do not sell or distribute any of your burnt XBox Games. It is highly illegal and will get your self locked up.
  • Don't use over a 2.4x recording speed it will increase your chances of a write error and that will be a waste of a DVD.

Things You’ll Need:

  • IBurn360 This is the program you use. You can get that here - http://idog.appleguru.org/Home.html
  • X360 ISO Hacker which can be found here - http://www.wattks.com/macosx/x360/x360.html
source: warez-bb.org

About SATA Hard Drives

SATA stands for Serial Advanced Technology Attachment, a device in the computer motherboard. SATA, which uses a serial connection, replaces the older and slower parallel ATA (Advanced Technology Attachment) also known as PATA (Parallel Advanced technology Attachment). SATA utilizes thinner cables; it cools more effectively while running more reliably than ATA.

Function

Hard Disk Drive Hard Disk Drive The primary function of a SATA is to perform transmission of data in serial mode, one bit per time. It transfers data between the motherboard and other devices that provide mass storage, such as a hard drive, CD-ROM drives, and other components, such as RAM (Random Access Memory) and CPU (Central Processing Unit) of a computer. SATA supports all ATA and ATAPI (Advanced Technology Attachment with Packet Interface).

Types

There are different types of a Serial ATA: SATA 1.5Gb/s, SATA 3Gb/s, SATA 6Gb/s. SATA 1.5Gb/s, also known as, SATA/150 or SATA I, provides a transfer rate of 1.5 gigabits per second. The second type is SATA 3Gb/s or SATA/300, which provides a transfer rate of 3 gigabits per second. Another name for SATA 3Gb/s is SATA 2 or SATA II, which used to be the name of the SATA-IO (Serial ATA International Organization), a committee that defines the standards. The newest type of SATA is the SATA 6Gb/s or the SATA/600, which provides a transfer rate of 6 gigabits per second. The SATA 6Gb/s doubles the maximum throughput of the SATA300, which also benefits the flash read speeds.

Features

SATA cable SATA cable A SATA is a serial link or a single cable that has a minimum of four wires. SATA comes with flat cables compared to the older PATA, which has bulkier cables. A SATA cable can extend up to 1 meter long, while the PATA cable can only extend up to 40 centimeters long.

Considerations

When deciding on which SATA type to use, one would need to take into consideration the minimum requirements of utilization and transfer rates. For a personal computer, a SATA I would suffice, however, for enterprise-wide use the higher the transfer rates, provided by SATA II and SATA/600, the more efficient and reliable is the outcome.

Prevention/Solution

Redundancy, efficiency and speed are important for enterprise environments; that is why utilizing a SATA over an ATA is essential. The port selectors of a SATA II can allow two host connections on one drive, thereby providing redundancy. When one port or host fails, the spare one can pick up or take over the functions of the primary host, keeping the storage available for connections. Using NCQ (Native Command Queuing) improves the overall performance of a SATA II. The NCQ will provide the SATA II drive the algorithm to help improve performance by determining the best way and order to execute the commands.

Psoriasis Drug Raptiva

FDA Advises Public of Serious Adverse Event with Psoriasis Drug Raptiva

The U.S. Food and Drug Administration today issued a public health advisory concerning three confirmed, and one possible report of progressive multifocal leukoencephalopathy (PML), a rare brain infection, in patients using the psoriasis drug Raptiva (efalizumab). Three of those patients have died. All four patients were treated with the drug for more than three years. None of the patients were receiving other treatments that suppress the immune system.

The FDA is reviewing this latest information. The agency will take appropriate steps to:

  • ensure that the risks of Raptiva do not outweigh its benefits;
  • that patients prescribed Raptiva are clearly informed of the signs and symptoms of PML; and
  • that health care professionals carefully monitor patients for the possible development of PML.

PML is caused by a virus that affects the central nervous system. PML usually occurs in people whose immune systems have been severely weakened. It leads to an irreversible decline in neurologic function and death. Symptoms may include unusual weakness, loss of coordination, changes in vision, difficulty speaking and personality changes. There is no known effective prevention or treatment.

Psoriasis is a chronic disease, for which a number of effective therapeutic options are available, including four other approved biologic agents, ultraviolent light therapy, and the drugs cyclosporine, acitretin, and methotrexate. Generally, treatment for psoriasis patients involves a rotation of therapies.

In October 2008, the product labeling for Raptiva was revised to highlight in a boxed warning the risks of life-threatening infections, including PML. At that time, the FDA directed Genentech, the manufacturer, to develop a risk evaluation and mitigation strategy (REMS) to include a medication guide to educate patients about the drug’s risks.

The FDA strongly recommends that health care professionals carefully monitor patients on Raptiva, as well as those who have discontinued the drug, for any signs or symptoms of neurologic disease, and that they periodically reassess the benefits of continued treatment. Patients should be aware of the symptoms of PML and contact their health care professionals immediately if they experience any such symptoms.

Raptiva is a once-weekly injection approved for adults with moderate to severe plaque psoriasis who are candidates for systemic (whole body) therapy or phototherapy. The drug works by suppressing T-cells (blood cells that help fight infection) in the immune system. These cells, when activated, migrate to the skin and cause inflammation which results in the red, inflamed and scaly patches of skin, which is associated with psoriasis. By suppressing T-cells, Raptiva decreases the function of the immune system which increases a patient’s susceptibility to infections.

Health care professionals and consumers may report serious adverse events (side effects) or product quality problems with the use of this product to the FDA's MedWatch Adverse Event Reporting program online, by regular mail, fax or phone.

--Online: www.fda.gov/MedWatch/report.htm
--Regular Mail: use postage-paid FDA form 3500 available at: www.fda.gov/MedWatch/getforms.htm and mail to MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787
--Fax: (800) FDA-0178
--Phone: (800) FDA-1088

Read the FDA’s 2009 Public Health Advisory

Monday, February 9, 2009

Wednesday, February 4, 2009

Safety Review of Xigris

FDA Issues Early Communication about a Safety Review of Xigris

The U.S. Food and Drug Administration today announced that it is working with the maker of Xigris (drotrecogin alfa activated), Eli Lilly and Company, to further evaluate the incidence of serious bleeding events and death in patients who receive Xigris, a drug used to treat severe sepsis (a blood stream infection).

A recent study and an accompanying editorial published in the journal Critical Care Medicine reported an increased risk of serious bleeding events and death in patients with sepsis and baseline bleeding risk factors who received Xigris. The study, a retrospective review of medical records of 73 patients who were treated with Xigris, found that serious bleeding events occurred in seven of 20 patients (35 percent) who had a bleeding risk factor versus two of 53 (3.8 percent) of patients without any bleeding risk factors. More patients with baseline bleeding risk factors died (13 of 20, or 65 percent) compared with patients without any bleeding risk factors (13 of 53, or 24.5 percent). As noted by the authors, limitations of this study include the retrospective design (looking back at events that already have taken place) and small patient population.

Xigris is known to increase the risk of bleeding. The drug’s current prescribing information (labeling) includes a warning that describes bleeding as the most common serious adverse effect and lists a number of risk factors that should be carefully considered when deciding whether to use Xigris. The labeling contraindicates the use of Xigris in several clinical situations where bleeding could lead to significant adverse reactions or death.

The FDA is not recommending that prescribers stop administering this medication. Consumers and health care professionals should notify the FDA of any complaints or problems associated with this product. These reports may be made to MedWatch, the FDA’s voluntary reporting program, by calling 800-FDA-1088, or electronically at www.fda.gov/medwatch/report.htm.

The FDA uses a variety of tools to communicate important and sometimes emerging drug safety information. Early Communications mean that the FDA has begun an ongoing safety review about an important drug safety issue that has not yet been fully analyzed or confirmed by the agency. The FDA will announce its conclusions and any resulting recommendations to the public when the review of Xigris is completed, which may take several months.

The full Early Communication can be found here: http://www.fda.gov/cder/drug/early_comm/drotrecogin_alfa.html

Monday, January 26, 2009

A Variety of Weight Loss Diets


XXI Century - the world of slim and different diets - a way to join the elite. However, not all dietary methods are so good and safe, as they say.
How to determine nutritional fraud
Offering a truly magical results, the new diet appears every week. There is more. There are smaller. Fat - is the enemy. Carbohydrates - are evil. Consumption of large quantities of water - the path to weight loss. Such demands are forced by surprise even knowledgeable consumers. As a result, it is an easy way for fraudsters podlovit trusting customers and sell them to the promised miracle. Before you can use another promising diet, we suggest you familiarize yourself with a few tips that will not allow you to be cheated.

Clear 26 lbs in 30 days!
Beware of diets that promise significant weight loss in a short period of time. Instant weight loss - not really!

Weight loss is based on a balance of positive emotions, exercise and diet. The most realistic figure, with the loss of weight - 1.5 - 3 lbs per week.

Another danger signal - diets that promise weight loss compulsory. Weight loss does not have guarantees, as well as depends on many factors.

Diets based on cabbage soup
Diets based on the consumption of certain product groups (eg, cabbage diet, grapefruit diet or a diet product) is not only dangerous, but are unrealistic for a long period.

Diet, focusing on a particular form of food can lead to malnutrition. Diet based on cabbage soup, for example, leads to a drastic reduction in consumption of protein and other nutrients necessary for your body.

The secret to losing weight
Some diet, who argue that taking the "secret" weight loss, only one really kept secrets - how to exhaust your wallet, or vital energy. There is no "magic methods, which contributes a large weight loss.
There is no 'secret' miracle weight loss treatment method ... just do not work.

The same can be said about the diet requires that you be specific devices, such as belts and massage devices, which are in fact not provide the promised results. Instead of blindly copying and using such «magic» tools and techniques, just a little change their habits, and be honest with themselves about the effort.

Radical calorie restriction and weight loss
Diets that restrict excessive calorie intake can lead to poor health.

All diet programs are based on reducing calorie intake (even such well-known as the Atkins diet). Here it is necessary to respect the fundamental rights, determine the limit, which does not lead to poor health. Be aware that a diet that imply the consumption of less than 900 calories - are dangerous from a medical point of view.

There are health-monitored program (for example, Valens) with a sharp reduction calorie level, but remain with the safety and efficacy. But, remember, all should be the measure.

Also remember that some low-calorie diet will give instant results, but you will lose the water, but not fat.

"Folk" dietary program
Programs that do not have sponsors, which can be reached at the consultations - are doubtful. Reasonable program must have developers who are responsible for their promises.

Nevertheless, even knowing who developed the method still does not mean that the person or persons competent in matters of weight loss, especially if you have health problems. Need to consult with your doctor or other skilled medical professionals before you use a diet, especially if you have any contraindications.

And, of course, you will reach the maximum of success if they attach maximum efforts.

Diet pills - all you need
Diets that require you to use special pills or supplements, as part of the program, aimed at making a profit, rather than weight loss.

Existing drugs for the management and control weight, which passed the clinical trials, require medical prescription. The drugs are not sold in pharmacies, can help with weight loss, but the results are usually small and time.

You will lose weight, eating one slice of toast a day less and think that this is all due to pill. Also remember that supplements and pills that promote weight loss, artificially stimulate the metabolism, increasing the frequency of heart rate artificially. They can not only upset the balance of the body, but also to resume the weight loss only in case of continuous use.

It sounds too good to be true ...
And, finally, to show once more vigilant when you hear the phrase "fast results". Weight loss requires time, there is a reasonable and safe way to get quick results. In addition, a description of any techniques or nutritional products for weight loss is usually always better, that it really is.